Test Shown to Reduce Early Cancer Deaths is Now Available to Patients

SignatureCLL

HUNTINGTON BEACH, Calif., Nov. 14, 2013 (SEND2PRESS NEWSWIRE) — SignatureCLL today announced that the first laboratory test ever shown in a clinical trial to improve one year survival rates in cancer is now available to patients with chronic lymphocytic leukemia (also called CLL). The U.S. cancer physician who invented the test and the British scientist who used it to make discoveries in leukemia will offer the test under the trade name SignatuRx(TM) through their own, newly-formed laboratory company.